Shares of Omeros Corporation (NASDAQ: OMER), a rising star in the biotech industry, are losing altitude after the company reported first-quarter earnings today. The stock was down 16% earlier this morning, but just 11.4% lower than …
LONDON, UK / ACCESSWIRE / May 18, 2017 / Active Wall St. blog coverage looks at the headline from Omeros Corp. …
Omeros gapped open higher Friday morning and has continued to rise in early trade. The stock is now up 4.73 at $18.82 on above average volume. Omeros has broken out to over a 2-week high and has re-crossed its 200-day moving average.
Nasdaq5mon
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ ... “Art Doyle,” an entity or group that self-identifies as having a short position in Omerosstock. Because of its ongoing legal action, including a number of steps aimed at …
Analysts think the stock price could gain 72% in the next 12 months… Biotech Stocks to Watch No. 2: Omeros Corp. (Nasdaq: OMER) Omeros Corp.'s (Nasdaq: OMER) OMS721 to treat IgA nephropathy, a condition that can lead to …
Omer Yurtseven finally arrived on North Carolina State's campus ... Now, Yurtseven is excited to get back to work at NC State and improve his draft stock for next year. "I feel like I have a special relationship with Coach Keatts, which is one …
Over the past 52 weeks, the stock is up only 51%. Shares of Omeros were last seen up over 15% at $19.75 on Tuesday, with a consensus analyst price target of $36.67 and a 52-week range of $7.20 to $19.95.
“Art Doyle” self-identifies as having a short position in Omerosstock. While the company does not routinely respond to defamatory statements, given this report’s egregious nature, the company elected to respond. This report is replete with ...
Omeros Corporation (OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMER at https://www.zacks.com/ap/OMER